Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Pain Therapeutics
 More »

  • Big Need in IBD: Drugs to Slow Progression
    ... Merck has several trials in various stages for IBD therapeutics. The firm is now ... of the disease, though not the severe pain sometimes associated with those symptoms, ...
    8-1-2013
  • Transition Scores Rights to Develop Lilly Osteoarthritis Pain...
    Transition Therapeutics is in-licensing TT-601, Eli Lilly's small molecule transcriptional regulator for the treatment of osteoarthritis (OA) pain. Per the agreement, Transition ...
    7-24-2013
  • Top 15 Job-Cutting Companies of 2013 (So Far)
    The developer of drugs for CNS disorders and pain cited a need to conserve cash following ... the remainder at former Perseid Therapeutics site in Redwood City, CA. Both sites ...
    7-11-2013
  • Up to $12M Deal Expands Acorda Offerings to Neuropathic Pain
    Therapeutics said today it acquired rights to an approved drug and a drug candidate about to enter Phase III, in a deal that expands the company's offerings to neuropathic pain ...
    7-9-2013
  • Companion Diagnostics: 52 Pick-Up
    ... alliance designed to discover and develop companion diagnostics and compounds for pain. ... Metamark will also be entitled to royalties on worldwide net sales of therapeutics and any ...
    5-9-2013
  • Exploring GPCRs as Therapeutic Targets
    former post-docs, Jonathan Violin, Ph.D., now head of biology at Trevena. He will discuss how Trevena is using receptor bias for clinical development of pain therapeutics. ...
    4-15-2013
  • Poland Invests in Biotech Infrastructure
    ... platform for the production of novel biologic therapeutics based on antibody fragments. ... treated with other dressing types and he says patients report less pain during healing. ...
    4-15-2013
  • Medicine: Getting Personal
    ... Frederick Miesowicz, COO and vp of manufacturing at Argos Therapeutics, presented a case ... to treat joint, muscle, tendon, or bone pain; Regenexx argued the treatment is a ...
    3-15-2013
  • People in the News
    Ph.D. , to regulatory scientist I, and Kasey Lawrence to technology specialist...Pain Therapeutics appointed Saira Ramasastry to its board of directors as an independent director. ...
    3-15-2013
  • Small Firms Look Optimistically to Future
    ... Cubist Pharmaceuticals is developing therapeutics for the acute care environment. "We're ... Therapeutically, Cubist focuses on antibacterials and, recently, nonopiate pain ...
    3-1-2013
  • Addressing Unmet Medical Needs with Complex Carbohydrate Chemistry
    Manchester, NH-based Boston Therapeutics developed this treatment under the name PAZ320 ... circulation that results in severe pain in the extremities; lower-limb ischemia is ...
    2-28-2013
  • Challenging the Limits of Protein Characterization
    ... all been implicated in aggregation of protein therapeutics and formation of particulates. ... to alter the pharmacokinetics (for pain relief, for example) or pharmacodynamics, ...
    2-1-2013
  • GVK BIO Enters Second Deal of the Year
    This early stage asset portfolio is focused around pain and inflammation. Earlier this month, GVK BIO entered into a joint partnership with Onconova Therapeutics to develop new ...
    1-28-2013
  • Drug Repurposing Rekindles Promise
    drugs continues to produce important therapeutics, particularly for disorders where no ... to determine whether it will decrease pain and improve other symptoms of FM. The ...
    1-25-2013
  • Acorda Wins $2.67M Army Contract for Spinal Cord Injury Drug...
    Acorda Therapeutics said today it won a $2.67 million contract from the U.S. Army Medical ... in other specific areas, including certain areas of pain and musculoskeletal indications. ...
    1-24-2013
  • More »

    Journal Articles

  • The Use of a CoolSense Device to Lower Pain Sensation During...
    Julio Wainstein, Gavriel Chimin, Zohar Landau, Mona Boaz, Daniela Jakubowicz, Gisele Godard, Yosefa Bar-Dayan
    Diabetes Technology & Therapeutics
    Device to Lower Pain Sensation During Finger Pricking While Measuring Blood Glucose in Diabetes Patients-A Randomized Placebo Diabetes Technology & Therapeutics Background: ...
  • Efficacy of Extended-Release Oral Diclofenac in Postoperative...
    Alireza Eslampour, Bizhan Malaekeh-Nikouei, Mojtaba Abrishami, Razie Bayani
    Journal of Ocular Pharmacology and Therapeutics
    Ocular Pharmacology and Therapeutics Purpose: Inadequate pain control after photorefractive keratectomy (PRK) surgery can be a source of distress for patients and ophthalmologists. ...
  • Transcutaneous Electrostimulation: Emerging Treatment for Diabetic...
    Michael Alvaro, Dinesh Kumar, Inderjeet S. Julka
    Diabetes Technology & Therapeutics
    Transcutaneous Electrostimulation: Emerging Treatment for Diabetic Neuropathic Pain Diabetes Technology & Therapeutics
  • Ocular Surface Disease and Glaucoma: How to Evaluate Impact on...
    Gemma Caterina Maria Rossi, Gian Maria Pasinetti, Luigia Scudeller, Paolo Emilio Bianchi
    Journal of Ocular Pharmacology and Therapeutics
    Journal of Ocular Pharmacology and Therapeutics Purpose. To record signs and symptoms of ... TF-BUT was related to IOP value (p<0.0001). The NEI ocular pain (OP) subscale was ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll